The first week of October brought with it a flurry of activity at Griffith University’s Institute for Glycomics as they...
Griffith's Institute for Glycomics has partnered with China Grand Pharma’s new Australian company Grand Medical Ltd to develop a drug to treat millions of people with respiratory illnesses.
Institute for Glycomics receives Federal Government grant to partner with China to create world-first drug to treat Hand, Foot and Mouth Disease (HFMD).
Two new clinical trials are set to begin at Griffith University’s Clinical Trial Unit (CTU) on the Gold Coast, as the Australian Government rolls out a new program to assist smaller companies and researchers to navigate complex regulations, in order to develop the next generation of medical devices, apps and therapeutic drugs.
From Phase 1 human trials for a Malaria vaccine, to studies aimed at treating osteoporosis and a number of trials into innovative life-saving stroke treatment, the Gold Coast Health & Knowledge Precinct is fast gaining a reputation as a leading location for clinical trials.
Griffith University’s Institute for Glycomics has partnered with Dextra Laboratories to launch the world’s largest commercial glycan array and bioanalytical service offering.
Queensland's Minister for Science and Innovation, The Honourable Leeanne Enoch MP, has included Griffith's Institute for Glycomics among facilities vital for the ongoing development of the state's knowledge economy
Griffith University’s Institute for Glycomics has been awarded a $1.1 million research grant to assist the Australian sugar industry.
Griffith awards scholarships in a bid to further develop the non-government community mental health workforce.
Acclaimed filmmaker and producer Rachel Perkins is best known for her work promoting and showcasing Indigenous stories and culture through film and television. But, born into a culture of Indigenous activism, her reach and impact extend well beyond the screen.
